Despite proven efficacy of osteoporosis medications, patients turn to dietary supplements marketed for bone health that lack ...

Osteoporosis is characterized by an imbalance in bone renewal, where bone loss outpaces bone replacement, leading to weakened, brittle bones. Various factors contribute to osteoporosis, including ...

While rare, premenopausal idiopathic osteoporosis is marked by low BMD and fragility fractures in younger women who don't ...

The Bon Secours’ Health Matters segment for this month focuses on Osteoporosis. It’s a condition that causes a person’s bones to become brittle and weak. Host, Amie Carter, interviews endocrinologist ...

The International Osteoporosis Foundation (IOF) has issued a landmark Position Paper identifying critical global barriers to osteoporosis care and calling for urgent change to improve access to ...

Osteoporosis causes brittle, porous bones. Typically, Original Medicare (Part A and Part B) covers most outpatient screenings, treatments, and inpatient surgical procedures for osteoporosis. A person ...

New denosumab biosimilars, Bildyos and Bilprevda, enhance access to affordable osteoporosis and bone disease treatments, promising significant patient benefits.

Medicare Part A covers fractures or osteoporosis-related injuries requiring surgery or hospitalization, while Medicare Part B covers outpatient treatments for osteoporosis, such as injectable drugs ...

The FDA approved Bildyos and Bilprevda as biosimilars to Prolia and Xgeva, expanding bone care options for osteoporosis, cancer and more.